Latest Retinitis pigmentosa Stories
Though based on mouse studies, the research bolsters the idea that humans suffering from these and other eye conditions may be able to help preserve function by adding antioxidants to their diet, and explains why this would work.
StemCells, a clinical-stage biotechnology company, has reported that its proprietary HuCNS-SC product candidate, when transplanted into a well-established animal model, can protect the retina from progressive degeneration.
StemCells, Inc. (NASDAQ:STEM) reported today that its proprietary HuCNS-SC(R) product candidate (purified human neural stem cells), when transplanted into a well-established animal model, can protect the retina from progressive degeneration.
CUMBERLAND, R.I., Oct.
VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ -- QLT Inc.
Neurotech Pharmaceuticals, a biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, has announced that the FDA has granted fast track designations for NT-501 for the treatment of visual loss in two indications - retinitis pigmentosa and the dry form of age-related macular degeneration.
LINCOLN, R.I., Sept. 3 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today that the U.S.
Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system (CNS) and autoimmune diseases, today announced its clinical update and results for its second quarter of 2008.
Case Western Reserve University School of Medicine, in collaboration with Copernicus Therapeutics, Inc.
Two blind patients in Britain became the first new owners of an artificial electronic retinal device last week.
- Pertaining to the surface or end opposite to the mouth in a radiate animal.